Posted by AGORACOM
at 10:28 AM on Friday, March 19th, 2021
Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce that its wholly-owned subsidiary, RLH Netherlands B.V. (the “Purchaser“), has completed the acquisition (the “Acquisition“) of SR Wholesale B.V. (“SR Wholesale“), one of the Netherlands’ premiere distributors for quality psychedelic truffles. In 2020, SR Wholesale generated over $2.44 Million in revenues[1], and over $822,0001 in gross profit, with approximately $400,0001 of cash and working capital currently on hand. SR Wholesale also distributes popular CBD products, cannabis seeds, smart shop items, and headshop products, among others. SR Wholesale has established a distribution network of over 400 companies that sell their products across Europe, including working with sub-distributors which provide products to over 1,000 shops in countries like the Netherlands, Germany, Spain, Czech, Greece, UK, France, and Portugal.
Founded in 2017, SR Wholesale has grown to become one of the most recognized and trusted distribution companies in the Netherlands. In connection with the Acquisition, Red Light Holland is excited to announce that Mr. Shai Ramsahai, Founder of SR Wholesale, has joined the Red Light Holland team on closing as Vice-President to oversee the integration of SR Wholesale into the Red Light Holland ecosystem, and grow the distribution business for Red Light Holland globally. The acquisition will create immediate synergies and enhance Red Light Holland’s growth and expansion strategy by:
Creating the necessary scale to support the growth of the continuing trend towards increased usage of psychedelics, including opening up the distribution channels to hundreds of stores for Red Light Holland’s iMicrodose Packs
Providing access to many new, unique and legendary product offerings within the Psychedelic sector including obtaining sole-ownership of the established Mister Maka Brand (www.MisterMaka.com) which produces Magic Truffles
Giving Red Light Holland the instant opportunity to white-label to help with brand growth, exposure and expansion
Creating new revenue generation opportunities across Red Light Holland’s e-commerce platform at www.iMicrodose.nl
Allowing Red Light Holland to have access to established brands and a vast array of products in sectors outside of Psychedelics, including existing inventory to reach sales opportunities and increased profit margins
Immediately becoming a distribution leader with expertise and know how, while looking to combine the complementary skill sets to focus on increasing SR Wholesale’s market share in the Netherlands and other global markets
Instantly, growing the Red Light Holland infrastructure and staff with current leaders in the psychedelic industry, including Mr. Shai Ramsahai, Founder of SR Wholesale, who will join Red Light Holland as the Company’s Vice-President
Gaining invaluable access to data and personal connections, including a plentiful and important list of email, production, white-label, retail store, retail product and social contacts
“The acquisition of SR Wholesale marks the latest step in the Company’s growth and expansion strategy, as we continue to move forward with a positive business outlook focused on achieving revenue growth, profitability and value creation for our shareholders. We expect this transaction to serve as a launchpad for Red Light Holland to broaden operations, create new homes for our iMicrodose packs and build brand exposure into multiple European markets. Others companies in the sector can keep telling people or assuming how people should consume psilocybin years from now, while we will continue offering people what they want right now, while concentrating on immediate revenue, profit and growth” said Todd Shapiro, the Chief Executive Officer and Director of the Company. “We are quite thrilled, after months of tough negotiations and careful due diligence, to move forward as the largest legal psychedelic distribution publicly traded company in the world.[2] As well, we are truly so pleased to work closely with Mr. Shai Ramsahai, who is one of the brightest, most determined and likeable entrepreneurs I’ve ever come across. And he is an absolute legend in the Netherlands!”
Posted by AGORACOM
at 9:12 AM on Friday, March 19th, 2021
Affinity Metals Corp. (TSX-V:AFF) (FRANKFURT: 34IA) (“the Company” or “Affinity”) is pleased to provide shareholders with an update of the Company’s ongoing exploration initiatives and general corporate activities.
The Company is currently awaiting assay results related to diamond drill programs in 2020 and 2021. Assay wait times have been significantly longer this year due to COVID 19 and increased exploration activities across Canada. Assay results from the Regal Property drill program and the Carscallen Extension Project are pending and the Company expects to receive them soon. Upon receipt of the assay results, the Company’s geological team will compile, verify and interpret the information as soon as possible for public release.
Specific property updates are as follows:
Regal Property: The Regal Property is located near Revelstoke, British Columbia within the northern end of the prolific Kootenay Arc and is south east and on trend with Rokmaster Resources’ Revel Ridge project. A total of 3,442 meters over 19 holes of diamond drilling was completed on Oct. 29, 2020 and core was delivered to the lab shortly after the program was completed. Assays results are pending and are expected to be received very soon. A follow up diamond drill program is being planned and assay results will be utilized to guide additional exploration for the upcoming exploration season.
Carscallen Extension Property: The Carscallen Extension Property is located near Timmons, Ontario and immediately adjoins the Carscallen Project currently being explored under a joint venture agreement between Kirkland Lake Gold Ltd. and Melkior Resources Inc. An initial drill program commenced on Nov. 19, 2020 designed to test a large zone identified by aerial acoustic geophysics on trend with the projected extension of the Shenkman-ZamZam gold system which has been the focus of the Melkior/Kirkland Lake Gold JV. Melkior has reported that the Shenkman-ZamZam zone extends for 800 meters and is open to both the northwest and southeast, as well as at depth. High grade intercepts reported by Melkior on the Carscallen include 23.5 g/t Au over 8.0 meters (Melkior news release 28/11/2019) and 25.7 g/t Au over 6.0 meters (Melkior news release 7/5/2020). To date, three diamond drill holes have been completed totalling 1,850 meters. Initial test samples were sent to the lab while detailed logging of the core was ongoing. Further samples were identified during core logging and have also been sent for assay. Results are pending.
Windfall North Property: Affinity Metals holds a 100% owned mineral property in Quebec, Canada that adjoins Osisko’s world class Windfall Lake project claim holdings. The property resides on the Eastern portion of the prolific Abitibi Greenstone Belt.
Affinity staked the North Windfall claims based on the interpreted northeast trend of the Windfall Lake Fault from the Windfall Lake gold deposit and plans to conduct geological and geophysical data compilation in order to generate drill targets in anticipation of a diamond drill program in 2021.
Rob Edwards, CEO of Affinity Metals, remarks, “As we look into 2021 we are very excited to establish plans for further advancement of our key properties. Unfortunately, assay labs have been plagued with delays as Covid-19 and the volume of exploration has caused a drastic increase in turnaround times from what the industry is accustomed to. The delays of setting a waypoint for 2021 exploration programs will hopefully be short lived as we expect results from the 2020 exploration programs soon.
Additionally, Affinity has good neighbors with good geology surrounding its key exploration properties. Recent developments on these properties bordering Affinity’s properties seem likely to continue to provide added exposure and value to the Company and its shareholders. Specifically, on the Regal Property in BC, Rokmaster Resources has expanded its 2021 Drill Program to 10,000 meters after positive results. The Kirkland Lake/Melkior joint venture in Ontario on the Carscallen Project has been expanded to 6,600 meters of diamond drilling and in Quebec, Osisko Mining continues to prove up their Windfall Project with some extremely encouraging drill results. Affinity and its investors have so much to look forward to in 2021.”
Posted by AGORACOM
at 4:38 PM on Thursday, March 18th, 2021
99.99% of the lithium leached in solution after 5 minutes at low temperature and without applying pressure.
completed EV battery characterization for 5 car makers
Pilot Testing Next
St-Georges Eco-Mining Corp. (CSE:SX)(OTC:SXOOF) (FSE:85G1) (CNSX:SX.CN)is pleased to provide an update on the initial testing phase of an array of electric vehicles batteries it received at its testing installations in Québec.
The Company has completed EV battery characterization for the following car makers: Tesla, General Motors (GM), Ford, Toyota, and Nissan. The batteries were sourced from industry aggregators. The Company’s chemists and metallurgists created synthetic powder clones of the metal’s components allowing the testing’s acceleration.
This is in line with the results obtained previously by the Company’s metallurgical team that was able to leach more than 99% of the cobalt and the nickel contained in the batteries. Furthermore, the aluminium foil used to hold the different metals in the batteries’ core remains intact and can be recycled.
The Company expects to confirm these results via a series of pilot tests as it now is in possession of car makers’ specific testing protocols. Testing will be documented and independently confirmed. The Company expects to initiate the next phase, metals purification, in April. The Company hopes to be able to reduce processing time and increase acid re-usage.
EVSX and St-Georges have also identified some of the key equipment required from industrial equipment manufacturers. They expect to be able to receive the electrolysis equipment during the month of May, allowing the manufacture of lithium hydroxide.
The Company had already disclosed on February 22, 2021, that additional tests to optimize the process of recovery of critical elements were to be conducted using synthetic compounds to move the development along faster. Work is ongoing at multiple locations, speeding up delivery and further protecting intellectual property.
Posted by AGORACOM
at 3:44 PM on Thursday, March 18th, 2021
Gross Proceeds of $3,621,680
Lead order of $1,000,000 from Eric Sprott
Proceeds for Prefeasibility Study on River Valley Platinum Group Metals (PGM) Project, one of North America’s largest undeveloped primary palladium projects
New Age Metals Inc. (TSXV:NAM) (OTC:NMTLF) (FSE:P7J) (“NAM” or the “Company“), is pleased to announce that it has completed a first tranche closing of its non-brokered private placement offering (the “Private Placement”) raising gross proceeds of $3,621,680, with lead order of $1,000,000 from Mr. Eric Sprott.
The Company has issued an aggregate of 22,260,500 units consisting of 20,760,500 non-flow through units (“NFT Units”) at a price of $0.16 per NFT Unit and 1,500,000 flow-through units of the Company (the “FT Units”) at a price of $0.20 per FT Unit.
Each NFT Unit consisted of one common share and one-half of one Common Share purchase warrant of the Company (each whole warrant, a “Warrant”). Each Warrant shall entitle the holder thereof to purchase one additional Common Share at an exercise price equal to $0.20 per share at any time up to 24 months from closing.
Each FT Unit consisted of one flow-through share of the Company that will qualify within the meaning of subsection 66(15) of the Income Tax Act (Canada) (“FT Common Share”) and one-half of one common share purchase warrant (each whole warrant, a “FT Warrant”). Each FT Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price equal to $0.25 at any time up to 24 months closing.
The Company intends to use the net proceeds from the sale of Units towards its exploration and development work on its projects. The primary use of proceeds from this financing will be for the completion of a Prefeasibility Study for the Company’s flagship River Valley Platinum Group Metals (PGM) Project, one of North America’s largest undeveloped primary palladium projects, and for general corporate and working capital purposes. The Company intends to use the net proceeds from the sale of FT Units towards its exploration work on both the Company’s PGM and Lithium divisions. This will include a maiden drill program on the Company’s Lithium Two Project in Manitoba and continued drilling at River Valley.
Posted by AGORACOM
at 8:35 AM on Thursday, March 18th, 2021
CE Mark received for in vitro diagnostic (IVD) test for the detection of SARS-CoV-2
Rapid results with ease of use – single 20-minute PCR cycle plus 5-minute detection process
High sensitivity – 104.73 c/PCR limit of detection with 95% confidence interval
High specificity – zero cross-reactivity on 19x respiratory infectious disease panel
High robustness – no impact on results from minor changes in process parameters
100% repeatability and laboratory precision observed
Sales launch in Europe planned for April 2021
XPhyto Therapeutics Corp. (CSE:XPHY)(OTC:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”), and its exclusive German diagnostics development partner, 3a-diagnostics GmbH (“3a”), are pleased to announce the European approval of its point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system (“Covid-ID Lab”). Covid-ID Lab is now registered within the European Union as a commercial in vitro diagnostic (CE-IVD) test.
“Our test is one of the fastest PCR-based COVID-19 tests currently approved. With a sample collection to result time of 25 minutes, Covid-ID Lab combines the speed of a rapid screening test with the accuracy of a PCR diagnostic,” said Hugh Rogers, CEO and Director of XPhyto. “Covid-ID Lab is designed for point-of-care testing, particularly in satellite and small-scale labs, such as transportation hubs, borders, care facilities, schools, pharmacies, and hospitality settings.”
Covid-ID Lab is a multiplex viral RNA probe kit based on the reverse transcriptase-polymerase chain reaction (RT-PCR) method. For assay performance, Covid-ID Lab requires only a single 20-minute PCR thermal cycle without prior RNA extraction as part of the sample preparation. Many widely available standard PCR instruments are suitable to run the test. Results are collected after the PCR cycle via easy-to-read optical indicator strips on a simple fluidics platform. The elimination of RNA extraction for sample preparation reduces the risk of cross-contamination and minimizes the need for lab materials and trained personnel. The rapid results, minimal laboratory equipment, and ease of use are expected to translate into reduced operating costs, greater convenience and portability.
During validation of the assay, the limit of detection for SARS-CoV-2 RNA was determined to be 104.73 c/PCR within a 95% confidence interval. Specificity of 100% against 19 other pathogens of serious respiratory infections was demonstrated on a respiratory verification panel. Precision was determined through evaluation of variance of the analysis results due to random deviations, a repeatability/intra-assay precision evaluation (same lab, user, equipment, etc.), and a laboratory precision evaluation (different lab, user, equipment, etc.). Robustness was measured by evaluation of the impact of minor changes on process parameters (transport medium, PCR cycler model, ramp rate, template volume, hybridization mixing ratio, etc.). The validation studies were carried out accordingly to ICH Q2 (R1) Validation of Analytical Procedures: Text and Methodology and VQ-015 Validation of Methods, European Medicines Agency. The quality management system was in accordance with EN ISO 13485: 2016 and EN ISO 9001: 2015.
Posted by AGORACOM
at 8:29 AM on Thursday, March 18th, 2021
Engaged to conduct and continue previous baseline studies at the Cañariaco Project
9B lbs copper, 2M oz gold and 54M oz silver in: Measured and Indicated Resources
Candente Copper Corp. (TSX: DNT, BVL: DNT) (“Candente Copper”, “the Company”) is pleased to announce that Yaku Consultores (“Yaku”) has been engaged to conduct and continue previous baseline studies at the Cañariaco Project located in Northern Peru. The work will be part of environmental impact studies and habitat protection for all exploration phases of permitting including drilling and also for the community and regional stakeholders.
“We are excited to be moving the Cañariaco project forward with Yaku’s environmental work and new engineering studies underway by Ausenco. Timing couldn’t be better as Cañariaco has been identified by both Goldman Sachs and Deutche Bank as one of the top copper projects needed to supply the upcoming supply-demand shortage for copper,” says Joanne Freeze, President and CEO, Candente Copper.
Yaku is comprised of a team of highly experienced professionals focused on providing quality environmental and social consulting services. These services contribute to the sustainable development of the environment and exceed regulations.
Candente Copper has recently obtained the respective authorizations from SERFOR and PRODUCE (Peruvian authorities for National Forest and Wildlife Services and the Ministry of Production) to conduct new monitoring of Water Quality, Air Quality, Noise Levels and Biology, Wild Flora and Fauna and Hydrobiology. Yaku has begun collecting new data within the project area which will add significantly to the studies that Candente Copper has been conducting such since 2004.
Given the difficult situation for the community with the COVID-19 epidemic, the company is also collaborating with local health facilities to assist in the protection and care of citizens in the area surrounding Cañariaco. To date, the Company has assisted with PPE supplies and the operation of emergency health equipment.
About Candente Copper
Candente Copper is a mineral exploration company engaged in the acquisition, exploration, and development of mineral properties. The Company is currently focused on its 100% owned Cañariaco project, which includes the Feasibility stage Cañariaco Norte deposit as well as the Cañariaco Sur deposit and Quebrada Verde prospect, located within the western Cordillera of the Peruvian Andes in the Department of Lambayeque in Northern Peru.
Please see https://www.candentecopper.com/investors/presentations for details from previous resource and engineering studies which delineated 9B lbs copper, 2M oz gold and 54M oz silver in: Measured and Indicated Resources of 752.4 million tonnes grading 0.45% copper, 0.07 grams per tonne (“g/t”) gold and 1.9 g/t silver (0.52% Cu equivalent) containing 7.533 B lb Cu, 1.67 M oz Au and 45.24 M oz Ag and Inferred Resources of 157.7 million tonnes grading 0.44% copper, 0.06 g/t gold and 1.8 g/t silver containing 1.434 B lb Cu, 0.3M oz Au and 8.932 M oz Ag.
Posted by AGORACOM-JC
at 4:10 PM on Wednesday, March 17th, 2021
If you haven’t heard of KWESST Micro Systems (KWE:TSXV) you’re not alone because the Company just listed for trading a couple of months ago – and it is probably the coolest new listing of 2020 if you love high-tech, covert defense systems that we only get to see in Tom Cruise movies.
KWESST is a leader in “soldier systems” which are technologies that increase the capabilities of soldiers, Let’s be clear right off the start, KWESST doesn’t sell weaponry. Rather, it sells technologies that make a big difference to the safety and effectiveness of soldiers.
For example, out in a field of combat, soldiers emit Electro Magnetic (EM) signatures that make them detectable by enemy combatants. KWESST has a battlefield decoy system that creates multiple false phantom signatures to spoof adversaries. This picture is worth 1,000 words.
Or perhaps the “TASCS” – Tactical Awareness and Situational Control System
An App and snap-on weapon adaptor that enables real-time streaming of situational awareness data of any kind from any source, including drones, direct to smart display devices and operational assets, for a common operating picture and networked engagement.
The company successfully achieved an important milestone under the contract announced in December 2020 for a key military customer.
This milestone entailed the integration of the Company’s TASCS IFM (Integrated Fires Module) for the 81mm Mortar Fire Control System into the Android Tactical Assault Kit (ATAK), the preeminent battlefield management system for NATO countries . As a result, the Company will now proceed to the next phase of the contract, involving live-fire trials at various U.S. military bases.
A world-first in digitizing the function of a mortar team, from the identification of the target to the aiming of the mortar.
We could go on about many other such technologies created by KWESST but this is AGORACOM after all and we want to get down to the business of KWESST, the highlights of which are as follows:
A developer of next-generation systems for forces around the world, including those of NATO and its allies
A leadership team whose experience spans decades and hundreds of millions of dollars in military and homeland security contracts
A sales and distribution network of agents that spans the globe
Partnerships with globally recognized OEM’s, including Samsung
Received a follow-on order for $1.1 Million from a key US Military Customer.
And last but not least, a secret weapon in its Executive Chairman David Luxton, whose companies under his leadership have generated over $1,000,000,000 (Yes, BILLION).
The soldier systems market is projected to hit $14.5 Billion by 2023 and, up until now, small cap investors have never had a company to participate in this lucrative (and SUPER COOL) market.
Posted by AGORACOM
at 10:31 AM on Tuesday, March 16th, 2021
Mountain Valley MD Holdings Inc.(the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce it is commencing husbandry animal trials under the supervision of The People’s Republic of Bangladesh’s Ministry of Fisheries & Livestock for the Company’s injectable solubilized Ivermectin technology, Ivectosol™ 1%.
“We are very excited to be welcoming Mountain Valley MD to The People’s Republic of Bangladesh and are proud that they have selected our country for important research projects and as a key production hub for its solubilized Ivectosol™ 1% product,” stated Bangladesh’s Foreign Minister H.E. Dr. A. K. Abdul Momen, M.P.
MVMD is working with its local partner R&G Group inside Bangladesh to quickly advance its research and development, and manufacturing capabilities inside the country.
MVMD’s Ivectosol™ 1%, a fully solubilized form of the anti-parasitic drug Ivermectin, will be tested in cattle, goat and poultry under the supervision of the Bangladesh Government’s approved and authorized laboratories and research institutes. The tests will be conducted by way of intra-muscular needleless injection of Ivectosol™ 1% in an effort to demonstrate superior pharmacokinetics in terms of CMAX (peak serum concentration that a drug achieves) and AUC (area under the curve) with advanced drug withdrawal time control, versus current commercially available forms.
The trials are scheduled to commence in early April, 2021 and are anticipated to take 30 days. The trial results are scheduled to be reviewed and approved by the Ministry of Fisheries & Livestock and Ministry of Health and will enable the Company to advance against immediate commercialization opportunities. The Company is finalizing production supply agreements with key Bangladesh pharmaceutical partners to produce its Ivectosol™ 1% for use and distribution throughout Bangladesh and as a production hub for broader global distribution. The production scheduling and pricing are currently being finalized under non-disclosure agreement (“NDA”), including securing the sufficient Ivermectin Active Pharmaceutical Ingredient (“API”) quantity for anticipated global demand.
“We’ve been extremely impressed by the speed and pace with which the Government of the People’s Republic of Bangladesh continues to provide our teams with incredible support for the testing and preparedness of an accelerated commercialization pathway for Ivectosol™ 1%,” stated Dennis Hancock, President and CEO of Mountain Valley MD. “Our pharmaceutical partners are both FDA and EU compliant and support our broader objectives to scale for global production. Securing top quality manufacturing within a competitive cost structure is critical to align with one of the core tenets of MVMD’s mission to ensure accessibility to our technology for even the most disadvantaged nations.”
Posted by AGORACOM-JC
at 8:53 AM on Tuesday, March 16th, 2021
A key milestone in digitization of the modern army
KWESST extending its ATAK integration capability to other customers and OEMs
Ottawa, Ontario–(March 16, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) today announced that it has successfully achieved an important milestone under the contract announced in December 2020 for a key military customer.
This milestone entailed the integration of the Company’s TASCS (Tactical Awareness Situational Control System) IFM (Integrated Fires Module) for the 81mm Mortar Fire Control System into the Android Tactical Assault Kit (ATAK), the preeminent battlefield management system for NATO countries . As a result, the Company will now proceed to the next phase of the contract, involving live-fire trials at various U.S. military bases.
“TASCS is designed to integrate into any battlefield management application,” said Jeff MacLeod, KWESST Found, President and CEO. “However, ATAK is the foremost and ubiquitous NATO battlefield management application, therefore we view the successful integration of TASCS applications into ATAK as key to widespread adoption of our TASCS system, and are pleased to have achieved this milestone event.”
The TASCS IFM Fire Control System for the 81mm mortar is a world-first in digitizing the function of a mortar team, from the identification of the target to the aiming of the mortar. It reduces the time it takes to engage adversaries and greatly increases the precision of mortar fire. TASCS has similar application across many other firing platforms beyond just the 81mm mortar, with a world market estimated by the Company at several hundred million dollars.
The Company added that its ability to use its TASCS system as a toolset to integrate tactical applications into ATAK has attracted attention from other military customers and OEMs. “We’re discovering that many potential customers require ATAK integration help,” added Jeff MacLeod. “We have already begun assisting some, and we are currently processing about a dozen other inbound enquiries for assistance, both domestic and international. It appears that this has the potential to become a separate business line unto itself, with recurring revenue.”
Posted by AGORACOM
at 8:46 AM on Tuesday, March 16th, 2021
Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“) an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, announces it has completed the sale and import (the “Transaction“) of the Company’s high-grade consumer packaged goods (“iMicrodose Packs“) from the Netherlands to Canada under a Health Canada psilocybin import permit obtained by CCrest Laboratories Inc. in partnership with Shaman Pharma Corp.
The Transaction between Red Light Holland and the Montreal, Quebec-based cGMP lab, CCrest Laboratories, is the first of a multi-phase project to expand into the mental wellness pharmaceutical sector by demonstrating a legally compliant route for supplying raw materials containing psychoactive molecules, produced abroad by Red Light Holland, and imported into Canada.
“Today is another ground-breaking, precedent setting and defining leap forward for the entire Psychedelic sector as Red Light Holland has successfully expanded the reach of iMicrodose packs across international borders. As interest in novel psychedelic therapies increase on a daily basis, we will continue to aim to take our natural-occurring packaged psilocybin products to global markets, allowing Red Light Holland to increase our distribution and sales channels. The agreement with Shaman Pharma to utilize its partnership with CCrest Laboratories is part of Red Light Holland’s growth strategy, complementing the international groundwork which we established in the Netherlands, as one of the only legal sources for producing natural raw materials containing psilocybin,” said Todd Shapiro, Chief Executive Officer and Director of Red Light Holland. “The collaboration with Shaman Pharma, who have successfully received our iMicrodose packs on Canadian soil, simply put, is a significant day for the Company and its shareholders. We are very proud to have our Netherlands grown Magic Truffles designed for responsible use via education and information, in Canada. They’ve arrived home and Red Light Holland continues to trailblaze across the world.”
The Transaction is performed with the intent of exploring continued collaboration beyond successfully completing the shipment of Red Light Holland’s consumer packaged goods under a Health Canada import permit. The multi-phase scientific undertaking by CCrest Laboratories is planned to perform each phase of developing viable ingredients to address the demanding requirements of clinical trials, patient’s Special Access Programs, and the downstream supply of production-ready substances.
“We are delighted to build a relationship with Red Light Holland as we access the global industry for the very best of both product supply and, with recognition of their position as a market leader in establishing a supply chain from Europe to North America, the ability to meet the exacting needs of a globalized medical marketplace,” stated Alex Grenier, Chief Executive Officer of Shaman Pharma and President of CCrest Laboratories. “Today, we succeeded in demonstrating our strong ability to navigate the stringent regulatory landscape for conducting international transactions of controlled substances and setting the bar for scientific excellence. Furthermore, through this collaboration with Red Light Holland, we were pleased to find that Mr. Shapiro’s vision and ethic is well aligned with compatible long-term objectives for pioneering the psychedelic therapy sector in a manner that exceeds the most complex compliance requirements.”
